1262230-99-8

Basic information

• Product Name: N-[(4-hydroxy-2-oxo-8-(3-methylphenyl)-2H-3-chromenyl)carbonyl]glycine
• Synonyms: N-[(4-hydroxy-2-oxo-8-(3-methylphenyl)-2H-3-chromenyl)carbonyl]glycine
• CAS NO: 1262230-99-8
• Molecular Weight: 353.331
• Mol File: 1262230-99-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-[(4-hydroxy-2-oxo-8-(3-methylphenyl)-2H-3-chromenyl)carbonyl]glycine(CAS DataBase Reference)
• NIST Chemistry Reference: N-[(4-hydroxy-2-oxo-8-(3-methylphenyl)-2H-3-chromenyl)carbonyl]glycine(1262230-99-8)
• EPA Substance Registry System: N-[(4-hydroxy-2-oxo-8-(3-methylphenyl)-2H-3-chromenyl)carbonyl]glycine(1262230-99-8)

Safety Data

• Hazardous Substances Data: 1262230-99-8(Hazardous Substances Data)

Upstream product

• 1262231-37-7 C₂₃H₂₃NO₆ 
• 1422006-23-2 C₁₆H₁₄O₄ 
• 1422006-22-1 C₁₄H₁₂O₃ 
• 1422006-21-0 C₁₄H₁₁ClO₃ 
• 4068-58-0 3-bromo-5-chloro-2-hydroxy benzoic acid 
• 321-14-2 5-chloro-2-hydroxybenzoic acid 

Relevant articles and documents

Stable Polymorphic Forms of Compound as Hypoxia Mimetics, and Uses Thereof

The polymorphic forms of the compound of Formula I, the preparation thereof including the preparation of the intermediates, the pharmaceutical compositions thereof and the uses of a polymorph above in the manufacture of medicaments for treating a disease,

COMPOUNDS AS HYPOXIA MIMETICS, AND COMPOSIITONS AND USES THEREOF

This invention relates to new compounds that can serve as hypoxia mimetics. This invention also relates to methods of increasing HIF levels or activity in a subject or treating a condition associated with HIF levels or activity in a subject by administeri